InvestorsHub Logo
icon url

Whalatane

01/16/22 6:16 PM

#366534 RE: studythosestocks #366532

Alm. The problem with the mineral oil placebo is that the R-IT supplemental data showed a significant increase in hsCrp by year 4
This is inconsistent with other CV risk reduction trials … particularly the JUPITER trial ( look it up ) that showed the link between hsCrp and CV risk reduction and lead the way for the approval of Crestor … the statin I’m on
Kiwi
icon url

Whalatane

01/16/22 6:19 PM

#366535 RE: studythosestocks #366532

Study sorry last post addressing both you and Alm
I agree AMRN should have sent someone like Dr Ketchum if possible, for this hearing
Kiwi
icon url

W0lf1

01/16/22 10:19 PM

#366548 RE: studythosestocks #366532

Don’t be sorry! Those idiots including Karim who can’t wait to cash in their free share should be sorry! Heck, in some countries they would jump off a tall building. But, No this management team can not manage a gas station! They are as greedy as they are incompetent!
Lets get rid of them all!

p.s., if you ever wondered why Amarin’s sales did not make a headway, well the U.K. meeting explained it all. The doofus reps are not admitted and are not granted by the medical Community. These reps are the ones who chugged bear for 4- years and got a Marketing Degree. If they were half serious about their presentation, their careers or the company that pays their wages with our money, they would have peeped for the meeting.
icon url

alm2

01/17/22 2:06 AM

#366552 RE: studythosestocks #366532

Study / kiwi/ /north

Study you must make sure this is sent Amarin and KM

This is exact the problem - and you emphasise quite clearly Amarin failings what has to be done in the future to ensur approvals are obtained

Thank you for such a detailed explanation of the problem
Alm
icon url

The Canes

01/17/22 9:11 AM

#366557 RE: studythosestocks #366532

From study's post #366532 "I know they haven't been trained fully yet, and part of me actually felt very sorry for them getting ambushed again. They haven't seen our first Ad Com and what an obvious ambush against Amarin that was. I'm not blaming them. Someone needs to prep these reps FULLY!"

That someone is management. I thought we had universal approval in Europe and all we had to do was negotiate pricing? I thought KM had considerable experience bringing a drug to market in Europe? UK is one of the biggest markets over there. Have we lost it before we started? Christ where is Alex Denner we need someone competent running the show.